FTC sues important pharmacy reward administrators about insulin price ranges The company introduced action from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing price of lifetime-saving insulin medicines. Do not pass up tomorrow's healthcare sector news Let Healthcare Dive's absolutely free https://eduardoqhxoe.liberty-blog.com/30750476/not-known-facts-about-healthcare-news